Home / World / US bans most departures from India amid rising COVID-19 situation.

US bans most departures from India amid rising COVID-19 situation.

The Biden administration will ban most travel from India from Tuesday amid the country’s coronavirus cases.

“On the advice of the Centers for Disease Control and Prevention, the administration will restrict travel from India starting immediately,” said White House press secretary. Jen PsakiJen Psaki, a deer photographed in a revolving Kevlar shirt after a comment on Biden gun control, the White House gave an ASL interpretation of the president̵

7;s co-location, the first time Pandemic threw a shadow over Biden’s first speech on. More Congress Said on friday

“This policy will be implemented with regard to the ultra-high COVID-19 containment and the variations circulating in India,” she added.

“The policy will take effect on Tuesday, May 4”

The move comes above international travel restrictions that require people to undergo negative test results before coming to the United States. The move is expected to have no effect on US citizens.

The coronavirus outbreak in India has worsened significantly in recent weeks. New cases in the country rose to more than 380,000 on a single day, according to figures from Our World in Data.

The country is scrambling amid a shortage of oxygen as the influx of COVID-19 patients has put further pressure on the Indian healthcare system.

Aid from the United States began arriving in the South Asian country on Thursday, including supplies of oxygen and raw materials to make 20 million doses of the AstraZeneca vaccine.

The Biden administration also said it would deliver the finished AstraZeneca vaccine to the country. But the move will not be immediate, as the finished image needs to pass first Food and Drug Administration safety checks.

The White House also considered India-funded proposals to waive the COVID-19 vaccine patent at the WTO, which supporters argue would provide more access to the vaccine to low-income countries.

The proposal was opposed by vaccine manufacturers and some experts said technical knowledge of vaccine production was a real hurdle, not a patent.

Psaki said earlier this week that the administration had not decided whether to support the waiver and was weighing on how best it would help to provide the global vaccine.

Updated at 2:54 PM

Source link